Should a patient on Vivitrol (extended‑release naltrexone) hold the scheduled injection that is due three days before a colonoscopy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Should Vivitrol Be Held Before Colonoscopy?

No, the Vivitrol injection should NOT be held and should be administered as scheduled 3 days prior to the colonoscopy. The timing of this injection does not interfere with the colonoscopy procedure itself, and maintaining the dosing schedule is critical to prevent relapse in patients with opioid or alcohol use disorder.

Key Reasoning

Why the Injection Should Proceed

The concern about holding Vivitrol before procedures stems from situations where opioid analgesia is expected to be needed perioperatively. However, colonoscopy is fundamentally different from surgical procedures:

  • Colonoscopy typically uses sedation (propofol, midazolam) rather than opioid-based anesthesia for the procedure itself
  • Post-procedure pain is minimal to absent in routine colonoscopy, requiring no opioid analgesia
  • The 3-day timeframe before the procedure is irrelevant to the colonoscopy itself—the concern would only arise if opioids were needed during or after

When Vivitrol Actually Needs to Be Held

According to the Society for Perioperative Assessment and Quality Improvement (SPAQI) consensus guidelines, extended-release naltrexone (Vivitrol) should be held for 24-30 days after the last injection before elective surgical procedures IF opioids are expected to be used perioperatively 1. This extended timeframe is necessary because:

  • The extended-release formulation provides therapeutic naltrexone levels for approximately 4 weeks
  • The active metabolite (6-β-naltrexol) has a half-life of 13 hours and accumulates during therapy
  • Antagonist effects may persist for 2-3 days after oral naltrexone stops, but much longer (24-30 days) after intramuscular injection 1

Critical Distinction: Colonoscopy vs. Surgery

A colonoscopy is NOT a surgical procedure requiring the 24-30 day hold period. The procedure:

  • Uses conscious sedation, not general anesthesia with opioids
  • Causes minimal discomfort that resolves within hours
  • Rarely if ever requires post-procedure opioid analgesia
  • Any discomfort is managed with acetaminophen or NSAIDs

Important Caveats

If Complications Occur

In the rare event that colonoscopy results in perforation or other complications requiring emergency surgery:

  • Regional analgesia (epidural, nerve blocks) should be the first-line approach 1
  • Non-opioid analgesics (acetaminophen, NSAIDs, ketamine) should be maximized
  • If opioids are absolutely necessary, much higher doses may be required to overcome the naltrexone blockade, and this should only be attempted in a monitored setting
  • The anesthesia team must be informed of the recent Vivitrol injection

Risk of Holding the Injection

Delaying or skipping the Vivitrol injection poses significant risks:

  • Increased vulnerability to relapse to opioid or alcohol use
  • Loss of opioid tolerance creates overdose risk if the patient relapses 2
  • Disruption of the monthly dosing schedule may compromise long-term treatment adherence
  • The patient may be more sensitive to opioids at the end of a dosing interval or after missing a dose 2

Clinical Algorithm

For a patient on Vivitrol scheduled for colonoscopy:

  1. Administer Vivitrol as scheduled 3 days before colonoscopy
  2. Inform the gastroenterologist and anesthesia team about the Vivitrol injection
  3. Plan for non-opioid sedation (propofol, midazolam—standard for colonoscopy)
  4. Have a contingency plan for non-opioid pain management if complications occur
  5. Consider prescribing an opioid reversal agent (naloxone, nalmefene) for emergency use at home, as recommended by FDA labeling 2

Bottom Line

The 24-30 day hold recommendation applies to elective surgeries where opioid use is anticipated, not to colonoscopy procedures. Maintaining the Vivitrol schedule protects the patient from relapse risk, which poses far greater morbidity and mortality than the minimal theoretical risk of inadequate analgesia during a routine colonoscopy. The injection should proceed as scheduled.

References

Related Questions

What are the indications, dosing regimens, contraindications, and monitoring recommendations for naltrexone?
Is injectable depot naltrexone (380 mg intramuscular) appropriate for a 17‑year‑old adolescent?
How does naltrexone reduce alcohol cravings?
How long does it take for naltrexone to be cleared from the body after oral dosing and after the extended‑release injection (Vivitrol)?
Are there any drug interactions between naltrexone and rivaroxaban (Xarelto)?
How can I differentiate myocardial injury from non‑ST‑segment elevation myocardial infarction (NSTEMI) and what are the appropriate management steps for each condition?
In a patient switched from 112 µg levothyroxine (Synthroid) to 60 mg desiccated thyroid extract (Armour Thyroid) who now has elevated thyroid‑stimulating hormone, increased fatigue, improved brain fog, and modest weight loss, should the Armour Thyroid dose be increased or is this response typical?
Is almond milk safe for individuals with Hashimoto's thyroiditis?
What is the appropriate antibiotic regimen for diverticulitis based on disease severity and immune status?
In a menopausal woman using cyclic progesterone therapy (2 weeks on, 2 weeks off), how frequently should a withdrawal bleed occur?
What are the appropriate ICD‑10‑CM diagnosis and ICD‑10‑PCS procedure codes for cerebrospinal fluid (CSF) leak repair?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.